About Kentucky Neuroscience Research
Clinical Trials at Kentucky Neuroscience Research
During the past decade, Kentucky Neuroscience Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kentucky Neuroscience Research" #1 sponsor was "Eisai Inc." with 2 trials, followed by "Biosite" with 1 trials
sponsored, "Genentech, Inc." with 1 trials sponsored, "Genzyme, a Sanofi Company" with 1 trials sponsored and "Orion Corporation, Orion Pharma"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kentucky Neuroscience Research"
#1 collaborator was "Bayer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Kentucky Neuroscience Research
According to Clinical.Site data, the most researched conditions in "Kentucky Neuroscience Research" are
"Amyotrophic Lateral Sclerosis" (1 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials), "Parkinson's Disease" (1 trials) and "Refractory Partial Seizures" (1 trials). Many other conditions were trialed in "Kentucky Neuroscience Research" in a lesser frequency.
Clinical Trials Intervention Types at Kentucky Neuroscience Research
Most popular intervention types in "Kentucky Neuroscience Research" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "2 mg perampanel" (1 trials), "4 mg perampanel" (1 trials), "E2007 (perampanel)" (1 trials), "Levosimendan" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kentucky Neuroscience Research
The vast majority of trials in "Kentucky Neuroscience Research" are
6 trials for "All" genders.
Clinical Trials Status at Kentucky Neuroscience Research
Currently, there are NaN active trials in "Kentucky Neuroscience Research".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Kentucky Neuroscience Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kentucky Neuroscience Research, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".